Role of uterine artery embolisation in the treatment of symptomatic fibroids

Shivraj M. Ingole, Reshma P. Chavan, Rochan Pant, Sharad M. Malvadkar


Background: Uterine fibroids are the most common tumor in the female reproductive tract with high incidence of 40%. The objectives were to evaluate the technical success of the uterine artery embolisation in symptomatic fibroids and to evaluate improvement of symptoms and determine complications.   

Methods: Total 15 patients with symptomatic uterine fibroids were undergone uterine artery embolisation over a period of two years. The patients were followed with pelvic ultrasound immediately after the procedure and at 2 and 6 months intervals after procedure.

Results: There was significant reduction in size of fibroids and improvement of symptoms after the procedure. Technical success rate and clinical success rate are 96% and 93% respectively which are comparable with other international studies. The complications with this procedure are few. The most common complication is pelvic pain.

Conclusions: Uterine fibroids are the most common benign pelvic neoplasms, affecting nearly 40% of women of reproductive age. In the management of symptomatic fibroids uterine artery embolisation is a safe and effective alternative to surgery with markedly reduced morbidity and mortality.


Fibroids, Uterine artery embolisation

Full Text:



Sutton CJ. Treatment of large uterine fibroids. Br J Obstet Gynaecol. 1996;103(6):494-6.

Pokras R, Hufnagel VG. Hysterectomy in the United States, 1965-84. Am J Public Health. 1988;78(7):852-3.

Ravina JH, Herbreteau D, Vigneron CN, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346:671-2.

Worthington KRL, Popky GL, Hutchins FL. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology. 1998;208:625-9.

Goodwin SC, Mclucas B, Lee M, Chen G, Perrella R, Vedantham S, et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol. 1999;10(9):1159-65.

Siskin GP, Stainken BF, Dowling K. The feasibility of performing uterine fibroid embolization as an outpatient procedure: Experience in 73 patients. J Vasc Interv Radiol. 2001;11:189.

Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez JJ, et al. Uterine artery embolization for leiomyomata. Obstet Gynecol. 2001;98(1):29-34.

Walker W, Green A, Sutton C. Bilateral uterine artery embolization for myomata: results, complications and failures. Min Invas Ther Allied Technol. 1999;8:449-54.

Brunereau L, Herbreteau D, Gallas S. Uterine artery embolisation in the primary treatment of uterine leiomyomas; technical features and prospective follow up with clinical and sonographic examinations in 58 patients. Am J Roentgenol. 2000;175:1267-72.

Pelage JP, Le Dref, Soyer P, Kardache M, Dahan H, Abitbol M, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000;215(2):428-31.

Spies J, Niedzwiecki G, Goodwin S. Training standards for physicians performing uterine artery embolisation for leiomyomata. J Vasc Interv Radiol. 2001;12:19-21.

Hutchins FL, Kirsch WR, Berkowitz RP. Selective uterine artery embolisation as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparosc. 1999;6:278-84.

Worthington KR, Walker W, Adler L. Anatomic variations in the uterine arteries: A cause of failure of uterine artery embolisation for the management of symptomatic fibroids. Min Invas Ther Allied Technol. 1999;8:397-402.

Andrews RT, Brown PH. Uterine arterial embolization: Factors influencing patient radiation exposure. Radiology. 2000;217:713-22.

Bradley EA, Reidy JF, Forman RG, Jarosz J, Braude PR. Transcatheter uterine embolisation to treat large uterine fibroids. Br J Obstet Gynaecol. 1998;105:235-40.